
Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies
Keywords: dFdC, gemcitabine; dFdC-MP, gemcitabine monophosphate; dFdC-DP, gemcitabine diphosphate; dFdC-TP, gemcitabine triphosphate; dCK, deoxycytidine kinase; dFdU, 2′,2′-difluoro-2′-deoxyuridine; hENT1, human concentrative nucleoside transporter 1; PBS, phosphat